賓夕法尼亞州韋恩和上海2025年8月7日 /美通社/ -- 泰利福公司（NYSE: TFX），全球領(lǐng)先的醫(yī)療技術(shù)公司，今日宣布其旗下Rüsch? EZ-Blocker? 一次性使用雙側(cè)支氣管堵塞器已成功通過(guò)中國(guó)國(guó)家藥品監(jiān)督管理局（NMPA）的嚴(yán)格審評(píng)審批，并正式取得醫(yī)療器械注冊(cè)證（注冊(cè)證編號(hào)：國(guó)械注進(jìn)20252080316）。這不僅是泰利福中國(guó)產(chǎn)品組合的一次重要升級(jí)優(yōu)化，更為公司在華業(yè)務(wù)的增長(zhǎng)注入強(qiáng)勁動(dòng)力。

泰利福Rüsch? EZ-Blocker?一次性使用雙側(cè)支氣管堵塞器

泰利福中國(guó)始終致力于為全球醫(yī)療市場(chǎng)提供創(chuàng)新的醫(yī)療解決方案，此次 Rüsch? EZ-Blocker?一次性使用雙側(cè)支氣管堵塞器在華獲批，是泰利福深耕中國(guó)市場(chǎng)、滿(mǎn)足中國(guó)患者醫(yī)療需求的又一重要舉措。未來(lái)，泰利福將繼續(xù)優(yōu)化其在中國(guó)的產(chǎn)品組合，為推動(dòng)中國(guó)醫(yī)療健康事業(yè)的發(fā)展貢獻(xiàn)更多力量。

About Teleflex Incorporated

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in the world of healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

Teleflex is the home of Arrow?, Barrigel?, Deknatel?, LMA?, Pilling?, QuikClot?, Rüsch?, UroLift? and Weck? – trusted brands united by a common sense of purpose.

.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

© 2025 Teleflex Incorporated. All rights reserved. MCC-2025-0101

Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836

8